Sarcomas

Latest News

PARP Inhibitors May Be a Promising Treatment Strategy in Advanced Uterine Leiomyosarcoma
PARP Inhibitors May Be a Promising Treatment Strategy in Advanced Uterine Leiomyosarcoma

September 18th 2023

Kjersten Dosumu, DNP, MS, AGPCNP-BC, explains why investigators are optimistic about treating uterine leiomyosarcoma with olaparib and temozolomide.

Camsirubicin Leads to Tumor Size Reduction in 2 Patients With Advanced Soft Tissue Sarcoma
Camsirubicin Leads to Tumor Size Reduction in 2 Patients With Advanced Soft Tissue Sarcoma

August 13th 2023

gynecologic cancer
Olaparib Plus Temozolomide Induces Modest Results in Advanced Uterine Leiomyosarcoma

August 4th 2023

sarcoma
Cabozantinib Plus Nivolumab/Ipilimumab Minimizes Disease Progression in Metastatic Soft Tissue Sarcoma

June 7th 2023

sarcoma
Nirogacestat Significantly Reduces Pain Severity in Patients With Desmoid Tumors

June 4th 2023

Latest CME Events & Activities

Miami Breast 2024: Affiliated CE Symposia

March 7, 2024 - March 10, 2024

View More

The Latest on Acute Lymphocytic Leukemia

View More

A Focus on Acute Myeloid Leukemia

View More

Updates in Myelodysplastic Syndromes

View More

Patient, Provider, and Caregiver Connection: Addressing Pediatric and AYA Patient Concerns While Managing Hodgkin Lymphoma

View More

Multidisciplinary Management of TNBC: Immunotherapy, PARP, TROP2, Oh My!

View More

Community Practice Connections™: The Advent of TROP2-Targeted Treatment Approaches in HR+/HER2- Breast Cancer

View More

8th Annual School of Nursing Oncology™

August 10, 2024

Register Now!

Applying New Evidence in Multiple Myeloma Care from Frontline to R/R Disease

View More

Medical Crossfire®: How Do Clinicians Integrate the Latest Evidence in Treating Ovarian Cancer to Personalize Care?

View More

Medical Crossfire®: How Does Recent Evidence on PARP Inhibitors and Combinations Inform Treatment Planning for Prostate Cancer Now and In the Future?

View More

Medical Crossfire®: Where Are We in the World of ADCs? From HER2 to CEACAM5, TROP2, HER3, CDH6, B7H3, c-MET and Beyond!

View More

Medical Crossfire: How Has Iron Supplementation Altered Treatment Planning for Patients with Cancer-Related Anemia?

View More

Improving Outcomes in Autoimmune Hemolytic Anemias at the Intersection Between Hematology and Oncology Care

View More

Community Practice Connections™: 5th Annual Precision Medicine Symposium – An Illustrated Tumor Board

View More

More News

© 2024 MJH Life Sciences

All rights reserved.